Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 9, 2001

View Archived Issues

Antitumor activity of new VEGFR2 inhibitor under study at Boehringer Ingelheim

Gilead achieves several key R&D milestones during Q3

Elan highlights Q3 developments

TAP prodrug of duocarmycin derivative shows increased tumor specificity

Rapid anthrax test will be available to U.S. laboratories next week

Alexion acquires rights to immune system targets

FDA issues nonapprovable letter for IntraDose

Early NDA submission planned for Cellegy's testosterone gel

FDA grants orphan drug status for Thymitaq in treatment of HCC

NeoOncoRx to develop and market elsamitrucin

Antiallergic effects of AZG-1743, a new diphenylmethyl piperazine derivative

Pirfenidone may be useful in asthma Rx according to data presented at recent Japanese meeting

Chest 2001: cilomilast reduces sputum neutrophil count in COPD patients

Clinical course of malignant pleural effusions in NSCLC not changed by rhuMAb-VEGF

Adenosine modulation by pentostatin shows beneficial effects in septic mice

Further subgroup analyses of PROWESS data presented at Chest 2001

TNFerade gene therapy + radiation safely shrinks tumors in phase I trial

Phase III trials of RSR-13 in NSCLC under consideration at Allos based on phase II survival data

New analgesic from Vita enters clinical trials

Cancer-related protease inhibitor from Wilex reduces tumor growth and spread at nontoxic doses

Novel compounds from Knoll inhibit monoamine reuptake, bind to 5-HT1A receptors

Recent patent covers BMS's new DPP-IV inhibitors

Carbamic acid-based IP receptor antagonists reportedly useful for bladder disorders, etc.

Aventis prepares beta-carboline inhibitor of IKK which prolongs cardiac graft survival

New series for obesity and sleep disorders disclosed by Actelion

Selective COX-2 inhibitors synthesized by Almirall Prodesfarma

Novel compounds described in recent patent as chemokine IL-8 antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...